India Hemostat Market

Hemostats, also referred to as hemostatic clamp, arterial forceps or pean are surgical tools used in surgical procedures to control bleeding. The hemostats were designed to clamp blood vessels of small size to manage blood flow in hemorrhagic cases. These devices are also used to grasp and secure superficial fascia during wound closure surgical procedures. The hemostats, with hinges and rings, are visibly similar to scissors. These instruments have a locking mechanism known as rachet that is used for clamping wherein the jaws of locking forceps come together, which helps in sealing the opening of the blood vessels. In many cases, the hemostats can be used to hold the subcutaneous tissues on the edges of the wound, while the tissue forceps are applied to the other edge to retract and gain better exposure to the wound site.

Market Dynamics

The prevalence of blood disorders leads to a boost in the India hemostat market .According to an article published in the Financila Express on May 9, 2023, with 42 Mn carriers, India is the Thalassemia capital of the world. At the same time , the huge costs of hemostats that use advanced microfibrillar technology cause patients from tier 2 and 3 cities to not receive appropriate treatment. According to an article published by PubMed-a free search engine for biomedical and life sciences data,people with insurance status (Medicare, Medicaid, commercial, self-pay, and unknown) do receive hemostats during surgical procedures in India. Thus, the Indian government is taking steps to assure adequate reimbursement since it recognises the importance of hemostats in the healthcare industry and their role in driving market growth over the forecast period.   

Key features of the study:

• This report provides in-depth analysis of the India hemostat market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year.
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players.
• It profiles leading players in the India hemostat market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans.
• Key companies covered as a part of this study include Ethicon Inc. .(a subsidiary of Johnson & Johnson Services,Inc.),Aegis Lifesciences,Eucare Pharmaceuticals (P) Ltd., Baxter, Axio Biosolutions Pvt Ltd, and Mil Laboratories Pvt Ltd.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics.
• The India hemostat market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the India hemostat market.

Detailed Segmentation:

• India Hemostat Market, By Product Form:
  • Mechanical
  • Flowable
• India Hemostat Market , By Product Base:
  • Gelatin
  • Celulose
• India Hemostat Market, By Application:
  • Surgeries
  • Trauma cases
• India Hemostat Market, By End Users:
  • Ambulatory Surgical Services
  • Hospitals
  • Clinics
• Company Profiles
  • Ethicon Inc.(a subsidiary of Johnson & Johnson Services,Inc.)
  • Aegis LifeScience
  • Eucare Pharmaceuticals (P) Ltd.
  • Baxter
  • Mil Laboratories Pvt Ltd
  • AxioBiosolutions Pvt Ltd